Advanced Research Strategies and Developments to boost the demand for Latin America Non-Invasive Prenatal Testing Market
Latin America Non-Invasive Prenatal Testing Market was worth USD 220 million in 2016 and is projected to be growing at a CAGR of 11.3%, to touch USD 370 million by 2021
(EMAILWIRE.COM, June 08, 2018 ) Noninvasive prenatal Testing (NIPT) is to enhance the detection of fetal chromosomal aneuploidies that analyzes cellular-free fetal DNA within the blood of a pregnant female.
Non-invasive prenatal testing is a DNA test that takes a look at maternal blood to screen pregnancies for the most commonplace fetal chromosome anomalies which include Trisomy 21 that is Down syndrome, Trisomy 18 Edwards syndrome, and Trisomy 13 Patau syndrome. Whereas NIPT can also decide the gender of the fetus and NIPT is exceedingly reliable in over 99% of Down syndrome instances. The results of the NIPT screening can assist a physician to decide the next steps, which includes whether or not to have a diagnostic take a look at like chorionic villus sampling (CVS) or accrued from the amniotic fluid or placenta, to make certain whether or not a child has a chromosome abnormality. Non-invasive prenatal checking out can be done any time after 9 weeks into your being pregnant earlier than another prenatal screening or diagnostic take a look at.
While centers for disease manipulate and Prevention additionally states in 2017 that older moms are much more likely to have an infant stricken by Down syndrome than more youthful moms.
View sample and decide: https://www.marketdataforecast.com/market-reports/latin-america-non-Invasive-prenatal-testing-market-2822/request-sample
The Latin America Non-Invasive Prenatal testing market was worth USD 220 million in 2016 and is projected to be growing at a CAGR of 11.3%, to the touch USD 370 million by using 2021.
Drivers and Restraints:
Increase in reimbursements for the NIPT zone accelerated the shift from invasive methods to non-invasive methods, and rise of maternal age (associated with an increase in the hazard of chromosomal abnormalities in infants) increase the market growth. Further, release and development of advanced and new technology and non-invasive parenteral trying out products also fuel the market growth.
However, loss of professional specialists as well as strict regulatory pointers and ethical hurdles sluggish down the system of approvals and advertising and marketing are impeding the market growth.
To know more read: https://www.marketdataforecast.com/market-reports/latin-america-non-Invasive-prenatal-testing-market-2822/
Geographic Segmentation
Latin America market vicinity consists of international locations which include Brazil, Mexico, Argentina, and closing nations of South America. Brazil is one of the most important markets in this location trailed by Mexico, Argentina, and Columbia. There’s capacity for a market growth in the future because of the presence of huge untapped markets.
Get your customized report: https://www.marketdataforecast.com/market-reports/latin-america-non-Invasive-prenatal-testing-market-2822/customize-report
The leading companies of the market include GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).
Scope of the report
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Non-invasive prenatal testing is a DNA test that takes a look at maternal blood to screen pregnancies for the most commonplace fetal chromosome anomalies which include Trisomy 21 that is Down syndrome, Trisomy 18 Edwards syndrome, and Trisomy 13 Patau syndrome. Whereas NIPT can also decide the gender of the fetus and NIPT is exceedingly reliable in over 99% of Down syndrome instances. The results of the NIPT screening can assist a physician to decide the next steps, which includes whether or not to have a diagnostic take a look at like chorionic villus sampling (CVS) or accrued from the amniotic fluid or placenta, to make certain whether or not a child has a chromosome abnormality. Non-invasive prenatal checking out can be done any time after 9 weeks into your being pregnant earlier than another prenatal screening or diagnostic take a look at.
While centers for disease manipulate and Prevention additionally states in 2017 that older moms are much more likely to have an infant stricken by Down syndrome than more youthful moms.
View sample and decide: https://www.marketdataforecast.com/market-reports/latin-america-non-Invasive-prenatal-testing-market-2822/request-sample
The Latin America Non-Invasive Prenatal testing market was worth USD 220 million in 2016 and is projected to be growing at a CAGR of 11.3%, to the touch USD 370 million by using 2021.
Drivers and Restraints:
Increase in reimbursements for the NIPT zone accelerated the shift from invasive methods to non-invasive methods, and rise of maternal age (associated with an increase in the hazard of chromosomal abnormalities in infants) increase the market growth. Further, release and development of advanced and new technology and non-invasive parenteral trying out products also fuel the market growth.
However, loss of professional specialists as well as strict regulatory pointers and ethical hurdles sluggish down the system of approvals and advertising and marketing are impeding the market growth.
To know more read: https://www.marketdataforecast.com/market-reports/latin-america-non-Invasive-prenatal-testing-market-2822/
Geographic Segmentation
Latin America market vicinity consists of international locations which include Brazil, Mexico, Argentina, and closing nations of South America. Brazil is one of the most important markets in this location trailed by Mexico, Argentina, and Columbia. There’s capacity for a market growth in the future because of the presence of huge untapped markets.
Get your customized report: https://www.marketdataforecast.com/market-reports/latin-america-non-Invasive-prenatal-testing-market-2822/customize-report
The leading companies of the market include GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China).
Scope of the report
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results